Cell Based Assays

Agenda Topics

• Apoptosis Assays
• Assays for Phenotypic Changes: Invasion, Migration, Angiogenesis
• Case Studies from Biotechnology and Pharmaceutical Companies
• Elements of Assay Development: A Nuts-and-Bolts Perspective
• High-Content Analysis (HCA) Assays
• Instrumentation for Cell-based Assays
• Metabolism-monitoring Assays
• Morphology Changes as a Readout
• Reporter Gene Assays and their Utility for Drug Discovery Projects

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Peter Antinozzi, Assistant Professor, Wake Forest University School of Medicine
Anne Bang, Director, Sanford Burnham Medical Research Institute
Nathan Bays, Senior Therapeutic Scientist, Merck and Co Inc
Robert Damoiseaux, Scientific Director, University of California Los Angeles
Anthony Mitchell Davies, Director, Trinity College Dublin
Cedric Gaggioli, Baby Team Leader, Université Nice Sophia Antipolis
Sung Wook Jang, Investigator, National Institutes of Health (NIH)
Eric Johnson, Associate Professor, University of Wisconsin
Jeffrey Kelly, Researcher, Promega
Robin Ketteler, Group Leader/Manager, University College London
Aydogan Ozcan, Chancellor's Professor, University of California-Los Angeles; Associate Director, California NanoSystems Institute (CNSI)
Michel Roberge, Scientific Director, University of British Columbia
Roland Wolkowicz, Associate Professor, San Diego State University